ASX/RAD (ASX/RAD)

Australian Securities Exchange: ASX/RAD · AUD

A$0.01

+0.00 (+25.0%)· Recorded snapshot

Market cap	21.7M
Revenue (ttm)	12.9M
Net income (ttm)	-57M
EPS (ttm)	-A$0.02
Shares out	4.3B
Volume	66,268
Beta	0.86

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 12.9M
Net income (ttm): -57M
EPS (ttm): -A$0.02
Market cap: 21.7M

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-30 13:30 UTC

Forward P/En/a

P25 14.6P50 21P75 31.9

Trailing P/En/a

P25 15.4P50 29.4P75 64.4

ROE-174.7

P25 -108P50 -50.6P75 1.1

ROIC-101.5

P25 -64.5P50 -33.5P75 0.8

Benchmarks · 1M

All ASX/RAD indicators

Market & fundamental data

Available fields

167

Groups with data

Currency

AUD

Showing 167 of 167 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	AUD
Country	Australia
Country code	AU
Earnings date	2026-11-26
Employees	14
Enterprise value	AUD 15.2M
Exchange	Australian Securities Exchange
Financial currency	AUD
Financial report date	2026-06-30
First seen	2026-05-10
Fiscal year end	June
Founded	2021
Industry	Biotechnology
Is primary listing	Yes
ISIN number	AU0000181851
Last earnings date	2026-02-26
Last refreshed	2026-10-30
Market cap	AUD 21.7M
Next earnings date	2026-11-26
Price	AUD 0.01
Price currency	AUD
Sector	Healthcare
SIC code	2834
Stock price date	2026-10-30
Symbol	asx/RAD
Website	https://www.radiopharmtheranostics.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings yield	-370.6%
EV/Sales	1.18x
FCF / EV yield	-347.57%
FCF yield	-243.38%
Industry forward P/E	28.82x
P/B ratio	0.97x
P/S ratio	1.69x
Sector forward P/E	34.06x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross margin	-266.89%
Operating margin	-411.63%
Pretax margin	-442.25%
Profit per employee	AUD -4.1M
Revenue per employee	AUD 918,938
ROA	-45.15%
ROA (5Y)	-31.05%
ROCE	-128.42%
ROE	-174.71%
ROE (5Y)	-115.2%
ROIC	-101.54%
SBC / revenue	18.7%
Tax / revenue	0.42%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth years	2
Net income growth years	0
Revenue growth	-1.05%
Revenue growth (Q)	-36.95%
Revenue growth (QoQ)	7.38%
Revenue growth 3Y	27.48%
Revenue growth years	0

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Depreciation and amortization	AUD 2.7M
EBIT	AUD -53M
EBITDA	AUD -50.3M
EPS	AUD -0.02
FCF per share	AUD -0.01
Financing cash flow	AUD 33.4M
Free cash flow	AUD -52.8M
Free cash flow minus SBC	AUD -55.2M
Gross profit	AUD -34.3M
Income taxes	AUD 54,440
Investing cash flow	AUD -5.4M
Net cash flow	AUD -25M
Net income	AUD -57M
Operating cash flow minus SBC	AUD -55.2M
Operating income	AUD -53M
Revenue	AUD 12.9M
Stock-based compensation	AUD 2.4M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	-6.16
Book value per share	AUD 0.01
Debt / equity	0
Interest coverage	-471.17
Long-term assets	AUD 38.2M
Long-term liabilities	AUD 18.9M
Net cash (debt)	AUD 4.1M
Net cash / market cap	19.08%
Net cash growth	-85.79%
Net debt / equity	-0.19
Piotroski F-Score	2
Property, plant and equipment	AUD 46,136
Shareholders' equity	AUD 22.3M
Tangible book value	AUD -13.5M
Tangible book value per share	AUD -0.00
Total assets	AUD 60.1M
Total cash	AUD 4.1M
Total debt	AUD 0
Total liabilities	AUD 37.8M
WACC	8.98%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.18
Current assets	AUD 21.9M
Current liabilities	AUD 18.9M
Current ratio	1.16
Net working capital	AUD -1.1M
Quick ratio	1.14
Working capital	AUD 3M
Working capital turnover	0.92

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-47.68%
Shareholder yield	-47.68%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	AUD 0.01
1D price change	25%
1M price change	-28.57%
1M total return	-28.57%
1W price change	11.11%
1W total return	11.11%
1Y price change	-79.17%
1Y return CAGR	-79.19%
1Y total return	-79.17%
20-day SMA	AUD 0.00
200-day SMA	AUD 0.02
3M price change	-64.29%
3M total return	-64.29%
3Y price change	-95.24%
3Y return CAGR	-63.05%
3Y total return	-94.96%
50-day SMA	AUD 0.01
50-day SMA vs 200-day SMA	50under200
52-week high	AUD 0.04
52-week high date	2025-12-16
52-week low	AUD 0.00
52-week low date	2026-10-27
6M price change	-75%
6M total return	-75%
All-time high	AUD 0.50
All-time high date	2021-11-25
All-time low	AUD 0.00
All-time low date	2026-10-16
Average true range (ATR)	AUD 0.00
Average volume	5.2M
Beta (1Y)	0.28
Beta (2Y)	0.71
Beta (5Y)	0.86
Change from 52-week high	-86.49%
Change from 52-week low	66.67%
Change from all-time high	-98.99%
Change from all-time low	66.67%
Change from open	25%
Day's gap	0%
Dollar volume	AUD 331
High price	AUD 0.01
Low price	AUD 0.00
Monthly RSI	27.71
Open price	AUD 0.00
Position in 52-week range	100%
Previous close	AUD 0.00
Price vs 150-day SMA	-65.99%
Price vs 20-day SMA	4.17%
Price vs 200-day SMA	-69.7%
Price vs 50-day SMA	-28.57%
Relative volume	0.01
RSI	47.03
Sharpe ratio	-0.65
Sharpe ratio (3Y)	-0.53
Sortino ratio	-0.95
Sortino ratio (3Y)	-0.76
Volume	66.3K
Weekly RSI	22.67
YTD price change	-80%
YTD total return	-80%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	3.6B
Shares change (QoQ)	39.34%
Shares change (YoY)	47.68%
Shares held by insiders	4.85%
Shares held by institutions	8.46%
Shares outstanding	4.3B

Deeper analysis on ASX/RAD

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this ASX/RAD report

Is a complete ASX/RAD research report available?

No complete published report is available for asx/RAD (ASX/RAD) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

ASX/RAD (ASX/RAD)

Price

Financial snapshot

Fair-value bridge

Latest news · ASX/RAD

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All ASX/RAD indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on ASX/RAD

Frequently asked questions